Smartwatch study aims to keep pregnant heart patients safer at home

NCT ID NCT06818760

Recruiting now Knowledge-focused Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a wrist-worn device can help monitor pregnant women with congenital heart disease. Researchers will track heart rhythms and other data from 50 participants to see if the wearable can detect early signs of trouble. The goal is to improve care and reduce the need for frequent clinic visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Masimo Smart Wristband
What this could lead to: If successful, this could lead to better home monitoring tools for pregnant women with heart conditions, potentially catching problems earlier.
What could go wrong: This is a small, early pilot study with only 50 participants, so results may not apply to everyone. The wearable may not detect all complications accurately.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital heart disease congenital vascular malformation histiocytoid cardiomyopathy pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONGENITAL CARDIOMYOPATHY CONGENITAL HEART DISEASE CONGENITAL VASCULAR DISORDER PREGNANCY RELATED

Smartwatch study aims to keep pregnant heart patients safer at home

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions